Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Arubendol
2. Asthmoprotect
3. Brethine
4. Bricanyl
5. Bricanyl Sa
6. Butaliret
7. Butalitab
8. Contimit
9. Kwd 2019
10. Kwd-2019
11. Kwd2019
12. Monovent
13. Taziken
14. Tedipulmo
15. Terbasmin
16. Terbul
17. Terbutalin Al
18. Terbutalin Ratiopharm
19. Terbutalin Stada
20. Terbutalin Von Ct
21. Terbutalin-ratiopharm
22. Terbutaline
23. Terbutaline Sulfate
24. Terbuturmant
1. Bricanyl
2. Terbutaline Hemisulfate
3. Tert-butyl-[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]azanium;sulfate
4. Bricanyl Turbuhaler
5. 576pu70y8e
6. 1,3-benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-, Sulfate (2:1) (salt)
7. Einecs 245-386-3
8. Unii-576pu70y8e
9. 1-(3,5-dihydroxyphenyl)-2-tert-butylaminoethanol Sulphate
10. Terbutaline Sulfate [usan:usp:jan]
11. Nsc 757336
12. (+-)-alpha-((tert-butylamino)methyl)-3,5-dihydroxybenzyl Alcohol Sulfate (2:1) (salt)
13. Benzyl Alcohol, Alpha-((tert-butylamino)methyl)-3,5-dihydroxy-, Sulfate (2:1)
Molecular Weight | 548.6 g/mol |
---|---|
Molecular Formula | C24H40N2O10S |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 8 |
Exact Mass | 548.24036665 g/mol |
Monoisotopic Mass | 548.24036665 g/mol |
Topological Polar Surface Area | 243 Ų |
Heavy Atom Count | 37 |
Formal Charge | 0 |
Complexity | 267 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Terbutaline sulfate |
Drug Label | Terbutaline Sulfate, USP, the active ingredient of Terbutaline Sulfate Injection, USP, is a betaadrenergic agonist bronchodilator available as a sterile, nonpyrogenic, aqueous solution in vials, for subcutaneous administration. Each milliliter of... |
Active Ingredient | Terbutaline sulfate |
Dosage Form | Tablet; Injectable |
Route | Injection; Oral |
Strength | 2.5mg; 1mg/ml; 5mg |
Market Status | Prescription |
Company | Bedford; Hikma Farmaceutica; United Biomedcl; Fresenius Kabi Usa; Lannett; Impax Labs; Akorn |
2 of 2 | |
---|---|
Drug Name | Terbutaline sulfate |
Drug Label | Terbutaline Sulfate, USP, the active ingredient of Terbutaline Sulfate Injection, USP, is a betaadrenergic agonist bronchodilator available as a sterile, nonpyrogenic, aqueous solution in vials, for subcutaneous administration. Each milliliter of... |
Active Ingredient | Terbutaline sulfate |
Dosage Form | Tablet; Injectable |
Route | Injection; Oral |
Strength | 2.5mg; 1mg/ml; 5mg |
Market Status | Prescription |
Company | Bedford; Hikma Farmaceutica; United Biomedcl; Fresenius Kabi Usa; Lannett; Impax Labs; Akorn |
Adrenergic beta-2 Receptor Agonists
Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Tocolytic Agents
Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete. (See all compounds classified as Tocolytic Agents.)
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Terbutaline Sulphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Terbutaline Sulphate, including repackagers and relabelers. The FDA regulates Terbutaline Sulphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Terbutaline Sulphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Terbutaline Sulphate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Terbutaline Sulphate supplier is an individual or a company that provides Terbutaline Sulphate active pharmaceutical ingredient (API) or Terbutaline Sulphate finished formulations upon request. The Terbutaline Sulphate suppliers may include Terbutaline Sulphate API manufacturers, exporters, distributors and traders.
click here to find a list of Terbutaline Sulphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Terbutaline Sulphate DMF (Drug Master File) is a document detailing the whole manufacturing process of Terbutaline Sulphate active pharmaceutical ingredient (API) in detail. Different forms of Terbutaline Sulphate DMFs exist exist since differing nations have different regulations, such as Terbutaline Sulphate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Terbutaline Sulphate DMF submitted to regulatory agencies in the US is known as a USDMF. Terbutaline Sulphate USDMF includes data on Terbutaline Sulphate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Terbutaline Sulphate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Terbutaline Sulphate suppliers with USDMF on PharmaCompass.
A Terbutaline Sulphate written confirmation (Terbutaline Sulphate WC) is an official document issued by a regulatory agency to a Terbutaline Sulphate manufacturer, verifying that the manufacturing facility of a Terbutaline Sulphate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Terbutaline Sulphate APIs or Terbutaline Sulphate finished pharmaceutical products to another nation, regulatory agencies frequently require a Terbutaline Sulphate WC (written confirmation) as part of the regulatory process.
click here to find a list of Terbutaline Sulphate suppliers with Written Confirmation (WC) on PharmaCompass.
Terbutaline Sulphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Terbutaline Sulphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Terbutaline Sulphate GMP manufacturer or Terbutaline Sulphate GMP API supplier for your needs.
A Terbutaline Sulphate CoA (Certificate of Analysis) is a formal document that attests to Terbutaline Sulphate's compliance with Terbutaline Sulphate specifications and serves as a tool for batch-level quality control.
Terbutaline Sulphate CoA mostly includes findings from lab analyses of a specific batch. For each Terbutaline Sulphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Terbutaline Sulphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Terbutaline Sulphate EP), Terbutaline Sulphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Terbutaline Sulphate USP).
LOOKING FOR A SUPPLIER?